B., ConstantinTeodosiu, D., Marimuthu, K., Macdonald, I
Nausea, vomiting, diarrhea, constipation, and stomach discomfort are common across the class, particularly early in treatment
Medium-term (6 months): Studies show 8-10% total body weight loss is achievable in compliant patients
The practical reality is that differences in anti-inflammatory effects between GLP-1 receptor agonists are likely modest and may be overshadowed by individual patient response, tolerability, and the degree of metabolic improvement achieved
Build a daily stress plan that pairs short practices with weekly therapy or group support to sustain gains
Additionally, it stimulates collagen production, which helps to smooth out fine lines and wrinkles